SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 95 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,539,895 | $11,540,000 | 4.03% |
| Bain Capital Life Sciences Investors, LLC | 6,264,420 | $20,422,000 | 1.62% |
| Samsara BioCapital, LLC | 2,189,199 | $6,243,000 | 1.21% |
| Omega Fund Management, LLC | 2,512,705 | $8,191,000 | 1.16% |
| Altium Capital Management LP | 1,160,000 | $3,782,000 | 1.04% |
| Sio Capital Management, LLC | 900,677 | $2,936,000 | 0.88% |
| Artal Group S.A. | 3,000,000 | $9,780,000 | 0.26% |
| Flagship Pioneering Inc. | 2,938,494 | $9,579,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 242,132 | $789,000 | 0.10% |
| Orbimed Advisors | 1,837,500 | $5,990,000 | 0.08% |